Integrated BioPharma, Inc. Share Price Other OTC
Equities
INBP
US45811V1052
Pharmaceuticals
Sales 2022 | 56.25M 4.69B | Sales 2023 | 50.67M 4.22B | Capitalization | 9.92M 827M |
---|---|---|---|---|---|
Net income 2022 | 3M 250M | Net income 2023 | - 0 | EV / Sales 2022 | 0.3 x |
Net Debt 2022 | 1.71M 143M | Net Debt 2023 | 1.36M 113M | EV / Sales 2023 | 0.22 x |
P/E ratio 2022 |
4.17
x | P/E ratio 2023 |
-292
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 20.22% |
Managers | Title | Age | Since |
---|---|---|---|
Riva Sheppard
CEO | Chief Executive Officer | 57 | 01/91/01 |
Christina Kay
CEO | Chief Executive Officer | 54 | 01/94/01 |
Dina Masi
DFI | Director of Finance/CFO | 63 | 17/05/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christina Kay
CEO | Chief Executive Officer | 54 | 01/94/01 |
Damon Desantis
BRD | Director/Board Member | 56 | 20/22/20 |
Eric Friedman
BRD | Director/Board Member | 76 | 04/20/04 |
1st Jan change | Capi. | |
---|---|---|
+55.32% | 819B | |
-6.75% | 351B | |
+13.56% | 329B | |
+10.68% | 298B | |
+16.57% | 242B | |
+2.04% | 225B | |
+13.31% | 217B | |
+8.48% | 168B | |
-2.81% | 158B |